Medicenna Therapeutics Corp. MDNAF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.08% | -473.17% | 15.59% | -16.13% | -34.01% |
| Total Depreciation and Amortization | -10.22% | -22.73% | -10.85% | 106.17% | 270.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -160.00% | 64.61% | -174.70% | 113.60% | -94.50% |
| Change in Net Operating Assets | -51.85% | 135.65% | -65.60% | 89.33% | 40.86% |
| Cash from Operations | -24.88% | 6.29% | -40.23% | 12.90% | -50.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -53.85% | -5.26% | -- | -- | -- |
| Issuance of Common Stock | 7,394.23% | -- | -100.00% | -100.00% | -99.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9,832.98% | -10.61% | -101.00% | -102.67% | -99.82% |
| Foreign Exchange rate Adjustments | 99.19% | 195.91% | -112.54% | 182.51% | -889.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.21% | 11.52% | -1,098.76% | 10.34% | -123.22% |